FDA Approves Pfizer’s COVID-19 Vaccine Booster for US Adults – Community News
Covid-19

FDA Approves Pfizer’s COVID-19 Vaccine Booster for US Adults

A health worker takes a dose of Pfizer-BioNTech coronavirus disease (COVID-19) vaccine from a vial during a vaccination event hosted by Miami – Dade County and Miami Heat, at the FTX Arena in Miami, Florida, US, August 5, 2021. REUTERS/Marco Bello

Nov. 19 (Reuters) – The U.S. Food and Drug Administration on Friday approved booster doses of Pfizer Inc (PFE.N) and BioNTech SE’s COVID-19 vaccine for all adults, a measure aimed at addressing dwindling protection among fully vaccinated people. Americans in the Face of Delta Variant-Driven Breakthrough Cases of the Disease.

Earlier in the day, Moderna (MRNA.O) said the FDA has extended emergency authorization of a booster dose of its COVID-19 vaccine to all adults 18 years and older. read more

An advisory panel from the U.S. Centers for Disease Control and Prevention is expected to meet later in the day to discuss whether the booster doses should be recommended for the wider population. read more

Register now for FREE unlimited access to reuters.com

Reporting by Manas Mishra in Bengaluru, editing by Caroline Humer and Bill Berkrot

Our Standards: The Thomson Reuters Trust Principles.